seed
Stage
1
Investors
About
Rnatives develops precision RNA-based gene regulating therapies using a proprietary microRNA platform combined with AI-driven methods to treat serious diseases.
Explore Rnatives's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.